CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-24 | Harmon Cyrus Director | Sale | −12,500 | $11.71 | $146K | 702,770 |
| 2026-07-23 | Harmon Cyrus Director | Sale | −12,500 | $11.58 | $145K | 715,270 |
| 2026-06-18 | Harmon Cyrus Director | Grant or award · Stock Option (Right to Buy) | +29,500 | 29,500 | ||
| 2026-01-20 | Harmon Cyrus Director | Sale | −10,000 | $26.88 | $269K | 727,770 |
| 2026-01-14 | Harmon Cyrus Director | Sale | −3,489 | $29.12 | $102K | 737,770 |
| 2025-12-22 | Harmon Cyrus Director | Sale | −2,881 | $28.53 | $82K | 741,259 |
| 2025-09-18 | Harmon Cyrus Director | Sale | −10,000 | $8.33 | $83K | 744,140 |
| 2025-09-18 | Harmon Cyrus Director | Sale | −3,086 | $8.32 | $26K | 117,028 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −10,000 | $8.04 | $80K | 754,140 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −1,914 | $8.08 | $15K | 120,114 |
| 2025-06-11 | Harmon Cyrus Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2024-12-11 | Harmon Cyrus Director | Sale | −7,958 | $8.66 | $69K | 764,319 |
| 2024-12-11 | Harmon Cyrus Director | Sale | −179 | $9.39 | $2K | 764,140 |
| 2024-12-10 | Harmon Cyrus Director | Sale | −8,256 | $9.37 | $77K | 772,277 |
| 2024-12-09 | Harmon Cyrus Director | Grant or award | +29,250 | 780,533 | ||
| 2024-07-30 | Harmon Cyrus Director | Sale 10b5-1 | −934 | $15.55 | $15K | 751,283 |
| 2024-07-29 | Harmon Cyrus Director | Sale 10b5-1 | −4,066 | $15.58 | $63K | 752,217 |
| 2024-07-11 | Harmon Cyrus Director | Sale 10b5-1 | −5,000 | $12.26 | $61K | 756,283 |
| 2024-06-28 | Harmon Cyrus Director | Sale 10b5-1 | −20,000 | $10.77 | $215K | 761,283 |
| 2024-06-14 | Harmon Cyrus Director | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 |
Page 1 of 4 · 62 trades